Cargando…

The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

It is estimated that around 30% of the population living in Western countries has metabolic dysfunction-associated steatotic liver disease (MASLD), a spectrum of pathology (not attributed to alcohol/substance intake) initiated by steatosis and progression toward inflammation and irreversible fibrosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Backer, Sean, Khanna, Deepesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576539/ https://www.ncbi.nlm.nih.gov/pubmed/37842470 http://dx.doi.org/10.7759/cureus.45231

Ejemplares similares

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
por: Chan, Wah-Kheong, et al.
Publicado: (2023)

The Role of Vitamin C in Human Immunity and Its Treatment Potential Against COVID-19: A Review Article
por: Moore, Austin, et al.
Publicado: (2023)

Laboratory and Point-of-Care Testing for COVID-19: A Review of Recent Developments
por: Kalia, Ravi, et al.
Publicado: (2022)

Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project
por: Nabrdalik, Katarzyna, et al.
Publicado: (2023)

Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity
por: De Nucci, Sara, et al.
Publicado: (2023)

Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
por: Staufer, Katharina, et al.
Publicado: (2023)

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study
por: Inciarte, Alexy, et al.
Publicado: (2021)

Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes—Interventional Study
por: Hachuła, Marcin, et al.
Publicado: (2023)

Creating interventions to transition long-lasting insecticide net distribution in Ghana
por: Glozah, Franklin, et al.
Publicado: (2022)

Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study
por: Wang, Qian, et al.
Publicado: (2021)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
por: Terada, Mari, et al.
Publicado: (2021)

Managing COVID-19 infection in a Young Acute Myeloid Leukemia Patient Successfully With Antiviral and Granulocyte Colony Stimulating Factor: Playing on a Sticky Wicket
por: Talwar, Dhruv, et al.
Publicado: (2021)

Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review
por: Li, Gang, et al.
Publicado: (2020)

Impact of COVID-19-associated Mucormycosis in Kidney Transplant Recipients: A Multicenter Cohort Study.
por: Meshram, Hari Shankar, et al.
Publicado: (2021)

Drug interventions for prevention of COVID-19 progression to severe disease in outpatients: a systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
por: Petersen, Johanne Juul, et al.
Publicado: (2023)

Liver and Renal Impairments in COVID-19 Patients of Madinah City of Saudi Arabia: A Cross-Sectional Study (2020)
por: Mohammedsaeed, Walaa, et al.
Publicado: (2023)

Adenoviral Infections in Bone Marrow Transplanted Adult Patients: A Review of the 44 Cases Reported in the Last 25 Years
por: Keramari, Stergiani, et al.
Publicado: (2021)

The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
por: Paklar, Natasa, et al.
Publicado: (2023)

Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023)

Sickle Cell Disease and COVID-19 Infection: Importance of COVID-19 Testing and Approach to Management
por: Umar, Zaryab, et al.
Publicado: (2022)

Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
por: Platek, Anna E., et al.
Publicado: (2023)

COVID-19: Its Impact on Delayed Management of Pre-established Chronic Conditions
por: Villacreses, Camila A, et al.
Publicado: (2023)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
por: Eskridge, Wayne, et al.
Publicado: (2023)

The Impact of the COVID-19 Pandemic on Orthopaedic Knee Procedures: A National Multicentered Analysis
por: Pizzarro, Jordan, et al.
Publicado: (2022)

The role of lung ultrasonography in COVID‐19 disease management
por: Boero, Enrico, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19) in Cancer Patients
por: Cancarevic, Ivan, et al.
Publicado: (2020)

The COVID-19 Mirage: A Young Biologist With an Atypical Presentation of a Zoonotic Disease During the COVID-19 Pandemic
por: Chiriboga, Jose D, et al.
Publicado: (2022)

Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial
por: Ried, Karin, et al.
Publicado: (2021)

Factors associated with the severity of COVID‐19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID‐19 Registry
por: Pizzamiglio, Chiara, et al.
Publicado: (2022)

Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics
por: Sait, Afrah S., et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19): Forecast of an Emerging Urgency in Pakistan
por: Chaudhry, Rabia M, et al.
Publicado: (2020)

Syndemics at play: chronic kidney disease, diabetes and COVID-19 in Pakistan
por: Ali, Inayat
Publicado: (2021)

Pneumomediastinum in COVID‐19 disease: Clinical review with emphasis on emergency management
por: Ganessane, Ezhilkugan, et al.
Publicado: (2023)

The Macklin Effect in COVID-19
por: Iqbal, Noreena, et al.
Publicado: (2021)

COVID-19 Management Missteps
por: Boudi, F Brian, et al.
Publicado: (2022)

The impact of cortisol in steatotic and non‐steatotic liver surgery
por: Cornide‐Petronio, María Eugenia, et al.
Publicado: (2017)

Hydropneumothorax With Persistent Air Leak in a Patient With Mild COVID-19 Disease
por: Pantazopoulos, Ioannis N, et al.
Publicado: (2022)

Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis
por: Muneeb Hassan, Muhammad, et al.
Publicado: (2023)

TREM-1, TREM-2 and their association with disease severity in patients with COVID-19
por: Fan, Ruyue, et al.
Publicado: (2023)

Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors
por: Takahashi, Yoshihisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vsp05tg1qhpuruts88his6ttnf